Barbara Klencke, Chief Development Officer at Sierra Oncology, Inc. (SRRA), bought 9,275 shares at $12.22 ($113K) on 2020-08-18, disclosed to the SEC on 2020-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.22 | 5,950 | $73K | 64.1% |
| 2 | $12.25 | 3,325 | $41K | 35.9% |
| Total | $12.23 avg | 9,275 | $113K | 100% |
| Filing → |
| TCRX | BUY | 2023-12-18 | $25K | — | Filing → |
| SRRA | BUY | 2019-08-26 | $101K | — | Filing → |